Anzeige
Mehr »
Login
Samstag, 28.12.2024 Börsentäglich über 12.000 News von 681 internationalen Medien
Wie Trumps Aussagen die Krypto-Landschaft verändern könnten: Beobachten Sie diese Aktie jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
212 Leser
Artikel bewerten:
(1)

Milliken & Company Launches OVIK Health

Finanznachrichten News

Company rebrands healthcare business as a strategic enabler

SPARTANBURG, S.C., Nov. 1, 2023 /PRNewswire/ -- Today, global diversified manufacturer Milliken & Company unveiled a new brand platform for its healthcare business. OVIK Health, as Milliken Healthcare Products, LLC, will now be known, represents a new chapter for Milliken's healthcare innovations-one that reflects its unique position in the marketplace and builds momentum for its portfolio of leading solutions the healthcare industry has come to depend on.

Global diversified manufacturer Milliken & Company unveiled a new brand platform for its healthcare business. Milliken Healthcare Products will now be known as OVIK Health,

"Launching OVIK Health marks a new era in our work to positively impact the healthcare industry," shares Halsey Cook, president and CEO of Milliken & Company. "Through OVIK, we reaffirm our commitment to providing innovative healthcare solutions and open the door to future opportunities that can heal, protect and support patients."

The rebranding begins today, with an expected completion date of December 1, 2023. Milliken Healthcare Products will transition to OVIK Health in all brand and visual instances; however, all current healthcare product names will remain the same. OVIK Health, as a subsidiary of Milliken & Company, will carry forward Milliken's portfolio of wound and burn dressings, compression solutions, cohesive bandages, and tapes.

OVIK Health's portfolio is defined by Milliken's chemical and textile expertise and enhanced by Andover Healthcare's cohesive and compression innovations, when Milliken formally acquired Andover Healthcare in 2019. Some of its most notable offerings include the proprietary Active Fluid Management® technology for wound dressings, the SelectSilver antimicrobial technology, and the EasyTear technology for cohesive and compression products. These offerings, along with Milliken's entire line of healthcare innovations, will continue to be available under OVIK Health.

"When we entered the healthcare business in 2005 and acquired Andover Healthcare in 2019, we were guided by the desire to help improve patients' lives globally with a range of superior products that are marked by dependability, ease-of-use, and innovative excellence," adds Shri Parikh, EVP of Milliken and president of OVIK Health. "That commitment does not change with the launch of OVIK Health. It unites us as a team of innovators with a single brand and clear mission of advancing healthcare technologies to improve patient care."

Customers, suppliers and distributors can expect individual communications regarding the rebrand in the coming weeks. To learn more about OVIK Health, visit OVIKhealth.com.

About OVIK Health
OVIK Health pioneers breakthrough products to help improve patients' lives-and the lives of those who care for them-around the world. Drawing on a legacy of textile manufacturing and bolstered by the spirit of creating a positive impact that will last generations, OVIK Health envisions a world where technical solutions can redefine patient outcomes for the better. Alongside mainstay medical products like wound and burn dressings, OVIK Health's portfolio includes compression solutions, cohesive bandages, and tapes that serve the traditional medical fields as well as the animal care and sports medicine markets. Learn more at OVIKhealth.com.

About Milliken
Milliken & Company is a global manufacturing leader whose focus on materials science delivers tomorrow's breakthroughs today. From industry-leading molecules to sustainable innovations, Milliken creates products that enhance people's lives and deliver solutions for its customers and communities. Drawing on thousands of patents and a portfolio with applications across the textile, specialty chemical, flooring and healthcare businesses, the company harnesses a shared sense of integrity and excellence to positively impact the world for generations. Discover more about Milliken's curious minds and inspired solutions at milliken.com and on Facebook, Instagram, and LinkedIn.

Milliken & Company est un chef de file mondial dans le domaine de la fabrication, dont l'accent mis sur la science des matériaux permet aujourd'hui de réaliser les percées de demain.

Photo - https://mma.prnewswire.com/media/2262541/OVIK_Announcement__Open_Graph___1.jpg

Logo - https://mma.prnewswire.com/media/2254813/Milliken_and_Company_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/milliken--company-launches-ovik-health-301974214.html

© 2023 PR Newswire
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.